Kendall Capital Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Rejuvenate Biorejuvenatebio.com𝕏Jun 2026
Rejuvenate Bio is a biotechnology company developing gene therapies aimed at treating age-related diseases, with a pipeline that includes a canine mitral valve disease (MVD) program.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)Daniel Oliver(CEO, Co-Founder)George Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)
BoardDavid Zhu(Director)
Co-investorsCompanion FundConnecticut InnovationsKdT Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.